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Previewspresent opportunities for drug discovery.
The ability of enzymes such as EZH2 to
reflect and amplify the underlying genomic
causes of disease suggests chromatin
modifierswill remain important therapeutic
targets for the foreseeable future.REFERENCES
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The evolutionary pathway of specialized metabolism often takes unexpected, perplexing turns. In this issue
of Chemistry & Biology, Feng and coworkers provide evidence for a unique phosphatase whose enzymatic
product plays a critical role in biofilm formation in Bacillus subtilis.Microbial biofilms have intrigued the
scientific community for centuries. Their
peculiarities have been influential in
prompting some of the earliest micro-
scopic studies as well as the more
modern, cutting edge molecular analyses
(Høiby, 2014). Although not given full
appreciation until the late 20th century,
biofilms have forged an expanding scien-
tific frontier that spans disciplines ranging
from healthcare to agriculture (Lappin-
Scott et al., 2014). Their effects, good
and bad, have continued to draw atten-
tion from researchers in many fields who
hope to identify and/or exploit interesting
and unique aspects of this ‘‘slimy’’ part
of the microbial world.
Despite the consensus that most mi-
crobes generate biofilms at some point
during their lifecycle, considerable varia-
tions exist in the mechanisms through
which biofilm formation is supported,
even among the most extensively studied
bacterial systems (Lo´pez et al., 2010).One of these systems, the Gram-positive
bacterium Bacillus subtilis, utilizes a com-
mon biofilm theme whereby a polysac-
charide matrix infused with proteins an-
chors cells to one another and a surface
(Vlamakis et al., 2013). While this and
other areas of biofilm formation tend to
follow common trends, other aspects of
the process seem to be species specific,
such as the signaling molecules that elicit
the biofilm response (Lo´pez et al., 2010).
In this issue of Chemistry & Biology,
Feng et al. (2014) add a very interesting
new layer to the requirements for biofilm
assembly in B. subtilis. These authors
provide evidence that not only does the
B. subtilis squalene synthase-like enzyme
(YisP) catalyze the formation of farnesol
(FOH) from farnesyl diphosphate (FPP),
but also that its product plays an impor-
tant role in biofilm assembly. Earlier work
by Lo´pez and Kolter (2010) originally pro-
posed YisP to be a squalene synthase
without truly identifying its reactionproduct. Additionally, Lo´pez and Kolter
(2010) demonstrated that when YisP was
knocked out in B. subtilis, the ability to
assemble biofilm was lost and therefore
surmised that squalene played an impor-
tant role in B. subtilis biofilm formation.
However, close inspection of the protein
sequence by Hu et al. (2013) during the
elucidation of the crystal structure for
YisP revealed that one of the canonical
aspartate-rich motifs found in all squalene
synthases was out of register in YisP.
Thus, with the YisP crystal structures
in hand (additional YisP structures were
solved for this work) and the discrepancy
found by Hu et al. (2013) in mind, the cur-
rent authors calculated the volume of the
YisP active site pocket and compared
it to the active site pocket volume of
the Staphylococcus aureus dehydrosqua-
lene synthase (CrtM) and human squalene
synthase (HsSS) enzymes. In comparing
these measurements, Feng et al. (2014)
realized that the YisP active site was likelyª2014 Elsevier Ltd All rights reserved 1421
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Figure 1. Effect of FOH Produced by B. subtilis on Biofilm Formation in a Community of
Mixed Species
(A) When FOH is contained within B. subtilis cells, a biofilm community of mixed species is maintained.
(B) As FOH from B. subtilis is released, the biofilm community is either broken apart or other species are
unable to join.
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cules of FPP needed for dehydrosqualene
or squalene biosynthesis. This prompted
them to test YisP with various prenyl
diphosphate substrates (GPP, FPP, and
GGPP) followed by chemical profiling of
the reaction products. Surprisingly, the
only product detected in these analyses
was the dephosphorylated form of FPP,
FOH. To confirm the role of the aspar-
tate-rich motifs in YisP, site-directed mu-
tants were constructed and tested. These
results showed that the second aspartate-
rich motif was necessary for phosphatase
activity. Restoration of the first aspartate-
rich motif in YisP had little effect on
enzyme activity and did not give YisP the
ability to catalyze a squalene synthase-
like reaction. These efforts unequivocally
demonstrated that YisP is an FPP phos-
phatase, not a squalene synthase.
Reflecting back to earlier work by Lo´pez
and Kolter (2010), where it was shown that
the B. subtilis YisP deletion strain (DyisP)
was unable to form biofilm, the authors
of the current article asked what the role
of FOHwas inB. subtilis biofilm assembly.
To address this, they supplied the wild-
type and DyisP strains with exogenous
FOH and observed no effect on wild-type
biofilm assembly, whereas biofilm forma-
tion was restored in the mutant strain.
The authors then delved deeper into the
role of FOH in B. subtilis biofilm formation1422 Chemistry & Biology 21, November 20,and suggested that it acts to rigidify the
membrane by altering the ‘‘phospholipid
gel-to-liquid crystal phase transitions’’.
Similar observationsweremade for staph-
yloxanthin and cholesterol, which are
known to play important roles in mem-
brane properties in S. aureus and eukary-
otic cells, respectively.
The current authors’ suggestion that
FOH has a positive effect on biofilm for-
mation in B. subtilis is intriguing when
considered in the context of studies with
Candida spp. (reviewed in Finkel and
Mitchell, 2011) andStaphylococcusaureus
(Jabra-Rizk et al., 2006; Kuroda et al.,
2007). For example, it has been shown
in Candida albicans that FOH inhibits fila-
mentation, a critical part of this species’
ability to construct biofilm. In S. aureus,
FOH has also been shown to affect biofilm
formation negatively, although the effect
was attributed to a less specific mecha-
nism than that of C. albicans. Interesting
to consider in this light is the effect FOH
producedbyB. subtilismight have in a bio-
film community. Would the FOH produced
by B. subtilis promote its own biofilm
formation while inhibiting those of other
species in a mixed biofilm community
(Figure 1), thus giving B. subtilis a
selective advantage?
A final question arising from the current
work is the evolutionary origin of YisP.
Given its sequence and structural similar-2014 ª2014 Elsevier Ltd All rights reservedities to CrtM and HsSS, where does YisP
fall in the evolutionary pathway? The
question here is whether these enzymes
evolved from a common precursor,
where one led to the other, or whether
they co-evolved independently. Based
on the conserved functional trait of
CrtM, YisP and HsSS all being inhibited
by zaragozic acid, one might assume
that CrtM represents a primordial gene
form that could have given rise to two in-
dependent evolutionary lines where one
led to YisP and the other to eukaryotic
squalene synthases, like HsSS. Certainly,
other routes of evolution are possible.
However, if we could piece together this
evolutionary maze, then perhaps we
would have another tool to help us un-
ravel the molecular wizardry Mother
Nature has used in capturing novel
terpene biosynthetic capabilities as so
elegantly demonstrated in the character-
ization of YisP by Feng et al. (2014).ACKNOWLEDGMENTS
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